Michael Friebe

Directeur Général chez m2f investment Ltd.

Profil

Michael Friebe is the founder of Neuromed AG, which was founded in 1993.
He is currently the Deputy Chairman-Advisory Board at SurgicEye GmbH, Co-Managing Director at m2f investment Ltd., Managing Director at IDTM GmbH, and Managing Director at FRIIH GmbH since 2014.
He also serves as the President at UMS-Neuromed since 2009.
In his former positions, he was the President & Chief Executive Officer at TomoVation GmbH, Chairman-Supervisory Board at PPA Technologies AG, Director at Safeplus International Holdings Ltd. from 2005 to 2006, Director at IntraOp Medical Corp.
from 2004 to 2009, and Non-Executive Director at Eckert & Ziegler BEBIG SA in 2012.
Dr. Friebe holds a graduate degree from Golden Gate University, undergraduate and graduate degrees from Universität Stuttgart, and a doctorate degree from the University of Witten.

Postes actifs de Michael Friebe

Sociétés	Poste	Début
UMS-Neuromed	President	01/04/2001
SurgicEye GmbH	Corporate Officer/Principal	-
m2f investment Ltd.	Directeur Général	-
IDTM GmbH	Directeur Général	-
FRIIH GmbH	Private Equity Investor	13/06/2014

Anciens postes connus de Michael Friebe

Sociétés	Poste	Fin
PPA Technologies AG	Président	02/06/2010
MC LIQUIDATION INC	Directeur/Membre du Conseil	30/03/2009
SAFEPLUS INTERNATIONAL HOLDINGS LIMITED	Directeur/Membre du Conseil	01/07/2006
ECKERT & ZIEGLER BEBIG	Directeur/Membre du Conseil	-
░░░░░░░░ ░░	░░░░░░░░░	-